Jt. Halavaara et al., DETECTION OF FOCAL LIVER-LESIONS WITH SUPERPARAMAGNETIC IRON-OXIDE - VALUE OF STIR AND SE IMAGING, Journal of computer assisted tomography, 18(6), 1994, pp. 897-904
Objective: We assessed the value of superparamagnetic iron oxide (SPIO
) particles on the detection of focal liver lesions by MRI. Materials
and Methods: Twenty patients with one to five focal liver lesions, pri
marily detected with ultrasonography and/or contrast-enhanced CT, were
evaluated further with unenhanced and iron oxide-enhanced MRI at 1.0
T. Superparamagnetic iron oxide particles were administered intravenou
sly as a slow infusion. Then T1-, T2-, and proton density-weighted SE
images were obtained. In addition, the performance of a short TI inver
sion recovery (STIR) sequence was evaluated. Results: The iron oxide c
ontrast medium had marked effects on liver signal-to-noise (S/N) and t
umor-to-liver contrast-to-noise (C/N) ratios but only minimal effects
on tumor S/N ratios in cases of malignant tumor foci. Lesion-to-liver
contrast, expressed as differences between the tumor and liver S/N rat
ios, improved very significantly after SPIO infusion with all four pul
se sequences. Contrast enhancement of the liver parenchyma was best in
T2-weighted SE images, but the tumor-to-liver C/N values were highest
with the postcontrast STIR sequence. The SPIO enhancement revealed a
number of additional focal lesions (31%), also foci under 1 cm in diam
eter. In three benign focal lesions, SPIO infusion produced a definite
reduction in the S/N ratio of the lesions in contrast to the minimal
change measured in malignant foci. The favorable performance of the ST
IR sequence contradicts the disappointing results previously obtained
at 0.6 T. Conclusion: Superparamagnetic iron oxide is a promising new
contrast medium for MR examinations of the liver, increasing the consp
icuity and reducing the detectability threshold of focal hepatic lesio
ns.